PMC:7755033 / 903-1321 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"30","span":{"begin":164,"end":168},"obj":"Gene"},{"id":"32","span":{"begin":202,"end":207},"obj":"Gene"},{"id":"38","span":{"begin":158,"end":163},"obj":"Species"},{"id":"39","span":{"begin":179,"end":182},"obj":"Species"},{"id":"40","span":{"begin":183,"end":186},"obj":"Species"},{"id":"41","span":{"begin":191,"end":201},"obj":"Species"},{"id":"42","span":{"begin":246,"end":256},"obj":"Species"},{"id":"47","span":{"begin":109,"end":111},"obj":"Species"}],"attributes":[{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Gene:59272"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Gene:43740568"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Tax:9606"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:2698737"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"Tax:11118"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Tax:2697049"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Tax:2697049"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:126910"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"o display no associated mutagenic or adverse effect(s). Molecular docking analyses revealed that most of the WS phytoconstituents exhibited potent binding to human ACE2 receptor, SAR-CoV and SARS-CoV-2 spike glycoproteins as well as the two main SARS-CoV-2 proteases. Most of the phytoconstituents were predicted to undergo Phase-I metabolism prior to excretion. All phytoconstituents had favorable bioactivity scores "}

{"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":56,"end":267},"obj":"Sentence"},{"id":"T13","span":{"begin":268,"end":362},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"o display no associated mutagenic or adverse effect(s). Molecular docking analyses revealed that most of the WS phytoconstituents exhibited potent binding to human ACE2 receptor, SAR-CoV and SARS-CoV-2 spike glycoproteins as well as the two main SARS-CoV-2 proteases. Most of the phytoconstituents were predicted to undergo Phase-I metabolism prior to excretion. All phytoconstituents had favorable bioactivity scores "}